Navigation Links
Gene promotes 1 in 100 of tumors
Date:12/8/2013

Researchers have identified a gene that drives the development of tumours in over one per cent of all cancer patients. This is the first time that the gene CUX1 has been broadly linked to cancer development.

The team discovered that, when CUX1 is deactivated, a biological pathway is activated that increases tumour growth. Drugs that inhibit the biological pathway are currently being used in the clinic and are in development thus highlighting a potential new targeted therapy for patients with this type of cancer-causing mutation.

Around 300,000 people in the UK each year are diagnosed with cancer, and for more than 3,000 of these patients, an inactive CUX1 gene may be an underlying factor for their disease.

"Our research is a prime example of how understanding the genetic code of cancers can drive the search for targeted cancer therapies that work more effectively and efficiently, says Dr David Adams, lead author from the Wellcome Trust Sanger Institute. "This could improve the lives of thousands of people suffering from cancer."

The team used genetic data from over 7,600 cancer patients, collected and sequenced by the International Cancer Genome Constortium (ICGC) and other groups. They found that in around one per cent of the cancer genomes studied, mutations deactivated CUX1, an event associated with tumour growth.

CUX1 is mutated at a relatively low frequency, but across many different types of cancer. Because previous studies focused on genes that are mutated at a high rate in one cancer type to find cancer drivers, CUX1 was missed as a driver of cancer.

"Our work harnesses the power of combining large-scale cancer genomics with experimental genetics," says Dr Chi Wong, first author from the Wellcome Trust Sanger Institute and practising Haematologist at Addenbrooke's Hospital. "CUX1 defects are particularly common in myeloid blood cancers, either through mutation or acquired loss of chromosome 7q. As these patients have a dismal prognosis currently, novel targeted therapies are urgently needed."

"Data collected from large consortia such the ICGC, provides us with a new and broader way to identify genes that can underlie the development of cancers," says Professor David Tuveson from Cold Spring Harbor Laboratory. "We can now look at cancers as groups of diseases according to their tissues of origin and collectively examine and compare their genomes."

The team silenced CUX1 in cultured cells to understand how inactivating it might lead to the development of tumours. They found that when CUX1 is deactivated, it had a knock-on effect on a biological inhibitor, PIK3IP1, reducing its inhibitory effects. This mobilises an enzyme responsible for cell growth, phosphoinositide 3-kinase (PI3K), increasing the rate of tumour progression.

The team has already identified several dozen other genes that when mutated at a low frequency could promote cancer development. They plan to silence these genes in mice to fully understand how their inactivation may lead to cancer development and the mechanisms by which this occurs.

"Drugs that inhibit PI3K signalling are currently undergoing clinical trial," says Professor Paul Workman, Deputy Chief Executive and Head of Cancer Therapeutics at The Institute of Cancer Research, London. "This discovery will help us to target these drugs to a new group of patients who will benefit from them and could have a dramatic effect on the lives of many cancer sufferers."


'/>"/>

Contact: Aileen Sheehy
press.office@sanger.ac.uk
44-012-234-92368
Wellcome Trust Sanger Institute
Source:Eurekalert

Related biology news :

1. Single protein promotes resistance to widely used anti-estrogen drugs
2. An economical, effective and biocompatible gene therapy strategy promotes cardiac repair
3. New Genetics educational resource promotes active learning
4. Breast milk promotes a different gut flora growth than infant formulas
5. NJIT professor promotes building material of millennium: Autoclave aerated concrete
6. Team finds gene that promotes drug resistance in cancer
7. Environmental complexity promotes biodiversity
8. Testosterone promotes reciprocity in the absence of competition
9. Dysfunctional chemokine receptor promotes candidiasis
10. Treadmill step training promotes motor function after incomplete spinal cord injury
11. Nanotherapy: Treating deadly brain tumors by delivering big radiation with tiny tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/19/2019)... ARLINGTON, Va. (PRWEB) , ... February 19, 2019 ... ... today announced the appointment of Mark Hozza as Chief Commercial Officer of the ... Mark is responsible for the performance, strategy, and alignment of all market research ...
(Date:2/13/2019)... ... February 13, 2019 , ... Carstens, Inc. is ... features Wi-Fi enabled RFID Locks that provide healthcare facilities with instant control of ... on the network for superior access control and shrinkage protection. For years WALLAroo cabinets ...
(Date:2/11/2019)... ... February 11, 2019 , ... Allotrope Foundation ... the phased release of the Allotrope™ Framework for standardizing scientific data and its ... released Allotrope™ Data Format (ADF) and application programming interfaces (APIs), and the Allotrope ...
Breaking Biology News(10 mins):
(Date:1/30/2019)... ... January 30, 2019 , ... The Society for Laboratory Automation ... discuss best practices for laboratory automation and screening. This year the conference will ... conference, Visikol will be at booth #345 and throughout the conference will highlight ...
(Date:1/24/2019)... , ... January 22, 2019 , ... Dr. Douglas Stramel ... Pall Veterinary Platelet Enhancement Therapy System (V-PET™) for nearly three years. ... Regenerative Cell Therapy since 2007 and began using V-PET™ 2016. V-PET™ is ...
(Date:1/20/2019)... ... January 17, 2019 , ... ... recently, the exclusive purview of physicians. That's changing as many services now exist ... consumer (DTC) laboratory testing market totaled $208 million in 2018, according to Kalorama ...
(Date:1/15/2019)... ... ... Congress designating January as Cervical Health Awareness Month , myLAB Box , ... the risk of Cervical Cancer. , Cervical cancer is a slow-growing cancer that ... STD and an STI that almost half of all American adults have. While there ...
Breaking Biology Technology: